Detalhe da pesquisa
1.
MEN1 mutations mediate clinical resistance to menin inhibition.
Nature
; 615(7954): 913-919, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36922589
2.
Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML.
Blood
; 143(15): 1513-1527, 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38096371
3.
The future of HOXA- expressing leukemias: Menin inhibitor response and resistance.
Curr Opin Hematol
; 31(2): 64-70, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38010951
4.
Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia.
Mol Cancer
; 22(1): 196, 2023 12 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38049829
5.
Characteristics and Outcome of Elderly Patients (>55 Years) with Acute Lymphoblastic Leukemia.
Cancers (Basel)
; 14(3)2022 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158832
6.
Allogeneic hematopoietic stem cell transplantation for therapy-related myeloid neoplasms following treatment of a lymphoid malignancy.
Leuk Lymphoma
; 62(8): 1930-1939, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33779471
7.
Blinatumomab or Inotuzumab Ozogamicin as Bridge to Allogeneic Stem Cell Transplantation for Relapsed or Refractory B-lineage Acute Lymphoblastic Leukemia: A Retrospective Single-Center Analysis.
Clin Lymphoma Myeloma Leuk
; 20(10): e724-e733, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32646833